Cardiac magnetic resonance tomography in hypertrophic left ventricular phenotype

• Conditions: I42.2; E85.4; Other hypertrophic cardiomyopathy; Organ-limited amyloidosis

• Registration Number: DRKS00022048
• Lead Sponsor: Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-29
• Study Completion: 2021-01-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

Patients with hypertrophic left ventricular phenotype (> 12mm wall thickness)

Exclusion Criteria

Incomplete or insufficient cardiac magnetic resonance tomography dataset, absence of a final cardiac diagnosis, ischemic scar, acute myocarditis, disagreement of the patient for scintific use of personal or medical data

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Differential diagnosis by using cardiac magnetic resonance tomography of patients with hypertrophic left ventricular phenotype, particularly cardiac amyloidosis vs. hypertrophic cardiomyopathie vs. hypertensive heart disease

Secondary Outcome Measures

Name	Time	Method
Cardiac and extra-cardiac characteristics of patients with hypertrophic left ventricular phenotype, i.e. cardiac amyloidosis, hypertrophic cardiomyopathy and hypertensive heart disease